Events

Associate Professor Veysel Kayser from the University of Sydney will provide a summary of the current state-of-play of the development of monoclonal antibodies (mAbs) as well as other antibody-based therapies and provide new advancements mainly from the group's lab.

Dr Illing from the Biomedicine Discovery Institute, Monash University, will present her team's success on applying mass spectrometry-based epitope discovery workflow to characterise peptides naturally presented by HLA-I on the surface of influenza and SARS-CoV-2 infected cells.

Professor Heidi Drummer, Program Director Program Director for Disease Elimination at the Burnet Institute in Melbourne, will present her latest work on developing a universal prophylactic vaccine against HCV.

Associate Professor Jessica Mar from AIBN, UQ, will discuss her group's studies which focus on the shape of gene expression distributions, specifically shape diversity, and how they reveal new insights into biology.

Professor Leann Tilley from the Bio21 Institute, University of Melbourne, will present her latest research on the mechanisms of action of and resistance to the antimalarial artemisinin, as well as the potential for a newly-discovered series of nucleoside sulfamates as agents against malaria and a broad range of infectious diseases.

Dr Kathryn Kemper, a quantitative geneticist from The Institute of Molecular Biosciences, will discuss her work on estimating the genetic influence on within-person variability for traits such as height and weight; and the relationships between longitudinal trait change and outcomes including musculoskeletal disease and all-cause mortality.

This Women in Science event focuses on the career progression of Level A and B female academics in STEM. Panellists include Professor Tilley form the Bio21 Institute, University of Melbourne, Professor Melissa Brown, the Executive Dean of the Faculty of Science, and a range of early- and mid-career researchers from a variety of disciplines, regarding how they have risen to the challenges of pursuing a research career in science

This is a mini-symposium and Q&A event where Prof Maree Toombs and Dr Jeremy Tarry, two of UQ's Indigenous academics, will discuss their experiences of being Aboriginal academics.

Dr Julie Pearce from the UQ Centre for Natural Gas will discuss the feasibility of CO2 geological storage in the Surat Basin, QLD.

Dr Claudia Simm from Monash University will present results from conducting a phenotypic screen against Candida species using compounds of the Medicines for Malaria Venture (MMV) Pathogen box.

Dr Laura McKemmish from the School of Chemistry, UNSW, will discuss teaching computational chemistry and programming for chemists.

This seminar featuring Dr Freda Jen from The Institute of Glycomics, Griffith University, will focus on the discovery of gonococcal vaccine antigens and drug candidates.

Professor Steven Bull from the Department of Chemistry, University of Bath, will describe efforts to use a biorefinery based approach to catalytically upgrade biorenewable monoterpene feedstocks into a variety of sustainable commodity chemicals, bioplastics and drugs that are currently derived from non-renewable petrochemical feedstocks. In the second half of the presentation, efforts into developing fluorescent chemical sensors as investigational tools for probing complex biological processes in cellular systems, including for the real-time detection of osteocyte bone resorbing activity in deep bone cavities, imaging of amyloid-beta plaques in mice brains and visualisation of drug induced liver damage will be described.

Professor Lisa Ng, the Executive Director of A*STAR’s Infectious Diseases Labs, will provide an overview of the pathophysiology of SARS-CoV-2 infection. She will describe its interaction with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression that provided useful insights in the successful development of vaccines and booster strategies.

Professor Benjamin Schulz from the School of Chemistry and Molecular Biosciences will present work on the development and use of glyco/proteomic analytical approaches for measuring the complexity of glycosylation and other post-translational modifications at systems levels to understand their dynamics and roles in fundamental biology, virology, and fermented beverages. 

Dr. Charlotte Oskam, Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, will discuss the methodology used to characterise the bacterial communities found within Australian ticks and the search for novel candidate pathogens, as well as bacterial genera of known tick borne pathogens and endosymbionts. Her team's findings show that without the use of molecular advances, such as next-generation sequencing, many bacteria of potential medical and veterinary interest could go undetected.

Join us to learn about SCMB's research collaboration with Aboriginal and Torres Strait Islander Peoples - from traditional medicine and novel phage therapeutics to natural hot springs

Professor Tuba Esatbeyoglu form the Institute of Food Science and Human Nutrition, Gottfried Wilhelm Leibniz University Hannover, Germany, will present her team's semisynthetic approach to the preparative formation of eight dimeric procyanidins from B-type, their isolation and elucidation of their structure.

Dr Mark Davies from the Doherty Institute, The University of Melbourne, will discuss the application of population genomics to advance vaccine design through to tracking the evolution and transmission of pathogenic clones of Streptococcus pyogenes.

Professor Debbie Silvester Dean from the School of Molecular and Life Sciences, Curtin University, will discuss her team's recent work elucidating reactions at the ionic liquid–solid electrode interface

Assoc Prof Tom Williams from the University of Bristol will present some recently published and new (unpublished) results on the phylogeny of Bacteria, the nature of the last bacterial common ancestor, the timescale of bacterial evolution, and the impact of the Great Oxidation Event (GOE) on bacterial genomes >2Ga.